Table 2.
Characterisation of death cases of the serious adverse events (SAEs) after oral contraceptive drugs
| Drug | No | Date* | Age | SAE | Death | Hospitalisation | Adverse event (PT) | Causality assessment |
| Drospirenone-containing oral contraceptives | 1 | 15 May 2012 | 28 | Yes | Yes | No | Pulmonary embolism | —† |
| 2 | 19 Nov 2012 | 26 | Yes | Yes | No | Hypoesthesia, pulmonary embolism, medication error |
—† | |
| 3 | 02 July 2014 | —† | Yes | Yes | No | Pulmonary embolism | —† | |
| 4 | 30 Mar 2016 | —† | Yes | Yes | Yes | Thrombosis, atherosclerosis | Possible | |
| 5 | 07 Apr 2016 | 35 | Yes | Yes | No | Thromboembolism | Possible | |
| Second/third generation oral contraceptives | 1 | 18 Jan 2016 | 32 | Yes | Yes | No | Cardiac arrest | Possible |
*Date on which recognising adverse event occurrence.
†— refers to missing data.
PT, preferred term.